Co-Diagnostics (HAM:C970) Accumulated Depreciation: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:C970 Co-Diagnostics Inc HAM:C970
61 GF Score
Price €5.55
GF Value €8.47
! 5 Warning Signs
View Full Analysis

What is Co-Diagnostics Accumulated Depreciation?

Co-Diagnostics HAM:C970 61 Accumulated Depreciation is €0.00 Mil as of Jun. 2026. GuruFocus rates HAM:C970 with a GF Score™ of 61/100 and a GF Value™ of €8.47. The stock has 5 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Co-Diagnostics's quarterly accumulated depreciation declined from Dec. 2025 (€-3.34 Mil) to Mar. 2026 (€0.00 Mil) but then stayed the same from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€0.00 Mil).

Co-Diagnostics's annual accumulated depreciation increased from Dec. 2023 (€-2.05 Mil) to Dec. 2024 (€-3.13 Mil) and increased from Dec. 2024 (€-3.13 Mil) to Dec. 2025 (€-3.34 Mil).

Co-Diagnostics Accumulated Depreciation Related Terms

Co-Diagnostics Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Co-Diagnostics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Co-Diagnostics Accumulated Depreciation Chart

Co-Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.55 -1.30 -2.05 -3.13 -3.34

Co-Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -3.34 0.00 0.00
HAM:C970
61GF Score
Co-Diagnostics Inc HAM:C970
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Co-Diagnostics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €0.00 Mil mean?
Co-Diagnostics (HAM:C970) has a Accumulated Depreciation of €0.00 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Co-Diagnostics and its competitors.
Is Co-Diagnostics' Accumulated Depreciation too high?
Co-Diagnostics' current Accumulated Depreciation is €0.00 Mil. Overall, Co-Diagnostics has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Co-Diagnostics' Accumulated Depreciation compare to AIDX and TRIB?
Co-Diagnostics' Accumulated Depreciation of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Co-Diagnostics and its competitors. Co-Diagnostics's current Accumulated Depreciation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Co-Diagnostics stock overvalued right now?
Co-Diagnostics (HAM:C970) has a current Accumulated Depreciation of €0.00 Mil. The stock's GF Value™ is €8.47, compared to a current price of €5.55 — trading 34.5% below its estimated fair value. The current Accumulated Depreciation is €0.00 Mil. Co-Diagnostics' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Co-Diagnostics (HAM:C970), the current Accumulated Depreciation is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Co-Diagnostics (HAM:C970) Overvalued in 2026?

Based on GuruFocus' analysis, Co-Diagnostics stock appears to be undervalued. The current stock price of €5.55 is trading 34.5% below its estimated GF Value™ of €8.47.

Key valuation signals for HAM:C970:

  • Accumulated Depreciation: €0.00 Mil
  • GF Value™: €8.47 vs. price of €5.55 (34.5% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the HAM:C970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Co-Diagnostics Business Description

Other Exchanges CODX:USA0A50:UK
Address 2401 S. Foothill Drive, Suite D, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
61GF Score

Get the complete analysis for HAM:C970

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€8.47
GF Value